In this context, IR and T2DM are considered as chronic inflammatory conditions due to the increased production of pro-inflammatory cytokines such as interleukin-6 (IL-6) or tumor-necrosis factor alpha (TNFα) (Basu et al. 2011). Here, IL6 is linked to type 2 diabetes mellitus.